Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chemoradiotherapy Combined With Serplulimab for Locally Advanced Cervical Cancer
NCT07340489Phase 2Recruiting
- Sponsor
- Tianjin Medical University Cancer Institute and Hospital
- Start
- Dec 2025
- Primary completion
- Nov 2027
- Modality
- Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Cisplatin micelle injection (HA132), paclitaxel in Cervical Cancer (CC), sponsored by Tianjin Medical University Cancer Institute and Hospital. Started Dec 2025; status: recruiting.
02
Drugs
Cisplatin micelle injection (HA132)paclitaxel
03
Conditions
Cervical Cancer (CC)
Beyond the preview
Go deeper on NCT07340489.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07340489.